Opthea announced the publication of a scientific review in the peer-reviewed journal Ophthalmology and Therapy. The publication, "Vascular Endothelial Growth Factor (VEGF) C and D Signaling Pathways as Potential Targets for the Treatment of neovascular (wet) AMD," underpins sozinibercept’s potential as a novel, first-in-class VEGF-C/D ‘trap’ to prevent blood vessel growth and vascular leakage in the retina and deliver superior visual outcomes in wet AMD patients when combined with standard-of-care anti-VEGF-A therapies. Read press release here: https://lnkd.in/ez62P5NG We want to thank the authors: Ian Leitch Mike Gerometta David Eichenbaum @Robert Finger Nathan Steinle Megan Baldwin Access the full publication: https://lnkd.in/eu2-_Bdt #Opthea #maculardegeneration #AMDResearch #wetAMD #ophthalmology #medicaleducation #biopharma #eyehealth #retinaspecialists #sozinibercept
Great paper! Amazing Medical Affairs team!
Director of Research, Retina Vitreous Associates of Florida, Collaborative Associate Professor, Morsani College of Medicine at the University of South Florida
1moI am proud to be part of this publication and the sozinibercept development program at Opthea!